Chugai Pharmaceutical Co Stock Performance
| CHGCF Stock | USD 46.34 5.27 12.83% |
The firm shows a Beta (market volatility) of 0.22, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Chugai Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Chugai Pharmaceutical is expected to be smaller as well. At this point, Chugai Pharmaceutical has a negative expected return of -0.0191%. Please make sure to confirm Chugai Pharmaceutical's expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to decide if Chugai Pharmaceutical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Chugai Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, Chugai Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 212.3 B | |
| Total Cashflows From Investing Activities | -118.9 B |
Chugai |
Chugai Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 5,031 in Chugai Pharmaceutical Co on September 1, 2024 and sell it today you would lose (397.00) from holding Chugai Pharmaceutical Co or give up 7.89% of portfolio value over 90 days. Chugai Pharmaceutical Co is currently producing negative expected returns and takes up 4.6969% volatility of returns over 90 trading days. Put another way, 41% of traded pink sheets are less volatile than Chugai, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Chugai Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chugai Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Chugai Pharmaceutical Co, and traders can use it to determine the average amount a Chugai Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0041
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CHGCF |
Estimated Market Risk
| 4.7 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Chugai Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chugai Pharmaceutical by adding Chugai Pharmaceutical to a well-diversified portfolio.
Chugai Pharmaceutical Fundamentals Growth
Chugai Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Chugai Pharmaceutical, and Chugai Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chugai Pink Sheet performance.
| Return On Equity | 0.29 | |||
| Return On Asset | 0.2 | |||
| Profit Margin | 0.30 % | |||
| Operating Margin | 0.42 % | |||
| Current Valuation | 39.67 B | |||
| Shares Outstanding | 1.64 B | |||
| Price To Earning | 19.49 X | |||
| Price To Book | 3.95 X | |||
| Price To Sales | 0.04 X | |||
| Revenue | 999.76 B | |||
| EBITDA | 419.43 B | |||
| Cash And Equivalents | 545.3 B | |||
| Cash Per Share | 331.48 X | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 865.88 X | |||
| Cash Flow From Operations | 279.63 B | |||
| Earnings Per Share | 1.71 X | |||
| Total Asset | 1.54 T | |||
| Retained Earnings | 500.19 B | |||
| Current Asset | 542.89 B | |||
| Current Liabilities | 107.7 B | |||
About Chugai Pharmaceutical Performance
By analyzing Chugai Pharmaceutical's fundamental ratios, stakeholders can gain valuable insights into Chugai Pharmaceutical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Chugai Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Chugai Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. Chugai Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7664 people.Things to note about Chugai Pharmaceutical performance evaluation
Checking the ongoing alerts about Chugai Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Chugai Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Chugai Pharmaceutical generated a negative expected return over the last 90 days | |
| Chugai Pharmaceutical has high historical volatility and very poor performance | |
| About 60.0% of the company shares are held by company insiders |
- Analyzing Chugai Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chugai Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Chugai Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chugai Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chugai Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chugai Pharmaceutical's pink sheet. These opinions can provide insight into Chugai Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Chugai Pink Sheet analysis
When running Chugai Pharmaceutical's price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |